BNP Paribas Financial Markets Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

BNP Paribas Financial Markets reduced its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 9.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,170 shares of the health services provider’s stock after selling 778 shares during the period. BNP Paribas Financial Markets’ holdings in Amedisys were worth $692,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of AMED. Alpine Associates Management Inc. grew its position in Amedisys by 0.9% in the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock worth $117,586,000 after acquiring an additional 11,000 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Amedisys by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after purchasing an additional 19,660 shares during the period. Calamos Advisors LLC increased its position in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after purchasing an additional 41,220 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Amedisys by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after buying an additional 9,004 shares during the period. Finally, Highbridge Capital Management LLC lifted its position in Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after buying an additional 83,200 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Up 0.1 %

Amedisys stock opened at $85.60 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a 50 day moving average price of $92.87 and a 200 day moving average price of $95.02. Amedisys, Inc. has a fifty-two week low of $84.06 and a fifty-two week high of $98.95. The company has a market capitalization of $2.80 billion, a PE ratio of 33.97, a price-to-earnings-growth ratio of 1.85 and a beta of 0.73.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.98 EPS. Research analysts expect that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.